Bovilis IBR marker live, lyophilisate and solvent for suspension for cattle.
Qualitative and quantitative composition
Per dose of 2 ml reconstituted vaccine:
Active substance(s):
BHV-1, strain GK/D (gE¯ ): 105.7 - 107.3 TCID50.
TCID50: tissue culture infective doses 50%
For the full list of excipients, see section " Pharmaceutical particulars".
Pharmaceutical form
Lyophilisate and solvent for suspension.
Lyophilisate: off-white to light pink-coloured pellet.
Solvent: colourless solution.
Clinical particulars
Target species
Cattle.
Indications for use
Active immunisation of cattle to reduce the intensity and duration of the clinical respiratory signs induced by an infection with BHV-1 and to reduce nasal excretion of field virus.
Onset of immunity:
An increase in immunity was demonstrated 4 days after intranasal vaccination and 14 days after intramuscular vaccination of 3 month old seronegative animals.
Duration of immunity:
After intranasal administration to 2 week old calves without maternal antibodies, immunity lasts at least until the age of 3-4 months, when the animals should be revaccinated. In the presence of maternally derived antibodies, the protection of the vaccine may not be complete until this revaccination.
Revaccination at 3-4 months of age results in protective immunity that lasts for at least 6 months.
Single intranasal or intramuscular vaccination of 3 month old animals provides protective immunity (reduction of clinical signs and reduction of viral excretion), which was demonstrated via challenge 3 weeks after vaccination. Reduction of viral excretion is maintained for at least 6 months after single vaccination.
Specific information:
No information is available on the efficacy of the vaccine to prevent a latent wild virus infection or to prevent wild virus re-excretion in the latent carrier.
Contra-indications
None.
Special warnings for each target species
The presence of maternal antibodies can influence the efficacy of the vaccination. Therefore it is recommended to ascertain the immune status of calves before vaccination is started.
Animals between the age of 2 weeks and 3 months should be vaccinated via the intranasal route only and the animals should be revaccinated via the intranasal or intramuscular route when the animals are 3-4 months old.
Special precautions for use
Special precautions for use in animals
Vaccinate only healthy animals.
After intranasal administration, the vaccine virus may spread to in-contact cattle. Cattle which need to remain totally free from BHV 1 antibodies should be separated from intranasally vaccinated animals.
Operator warnings:
In case of accidental self injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Adverse reactions
A slight transient rise in temperature (1 °C) can occur up to 5 days post vaccination.
An increase of nasal discharge can be observed after intranasal vaccination.
Use during pregnancy, lactation or lay
Can be used during pregnancy and lactation.
No information is available on the use of this vaccine in breeding bulls.
Interactions
Safety and efficacy data -in cattle from 3 weeks of age onwards- are available which demonstrate that this vaccine can be administered on the same day but not mixed with Bovilis Bovipast RSP.
Safety and efficacy data are available which demonstrate that for the 6-monthly intramuscular revaccination - in cattle from 15 months of age onwards (i.e. those that have previously been vaccinated separately with Bovilis IBR marker live and Bovilis BVD) - this vaccine can be mixed and administered with Bovilis BVD. The product literature of Bovilis BVD should be consulted before administration of the mixed products. The adverse effects observed after administration of one dose or an overdose of the mixed vaccines are not different from those described for the vaccines administered separately.
When mixed with Bovilis BVD at re-vaccination, the demonstrated efficacy claims for Bovilis IBR marker live are as follows:
- Active immunisation of cattle to reduce the fever induced by an infection with BHV-1 and to reduce nasal excretion of field virus.
- Duration of immunity : 6 months demonstrated by serological data.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Do not use together with immunosuppressive agents.
Amounts to be administered and administration route
Reconstitute the vaccine with the solvent Unisolve.
| Number of doses per vial | Volume (ml) of solvent needed | |
| 1 | 2 | |
| 2 | 4 | |
| 5 | 10 | |
| 10 | 20 | |
| 25 | 50 | |
| 50 | 100 | |
| 100 | 200 |
Dosage: a single dose of 2 ml reconstitued vaccine per animal.
Method of administration:
- from the age of 3 months onwards: intranasal or intramuscular.
- at an age between 2 weeks and 3 months: intranasal.
For intranasal administration (1 ml in each nostril), the use of a nozzle is recommended.
Vaccination schedule:
- Basic vaccination:
Vaccinate each animal with one single dose.
- Revaccination:
When the first vaccination is given between the age of 2 weeks and 3 months, the animals should be revaccinated with a single dose at the age of 3-4 months. Afterwards, revaccinate every 6 months.
When vaccination is started after the animals are 3 months old, the animals should be revaccinated with a single dose every 6 months.
For the 6-monthly revaccination, the vaccine may be reconstituted shortly before use with Bovilis BVD for use in cattle from 15 months of age (i.e. those that have previously been vaccinated separately with Bovilis IBR marker live and Bovilis BVD) and the following instructions should be used:
| Bovilis IBR marker live | Bovilis BVD | |
| 5 doses | + | 10 ml |
| 10 doses | + | 20 ml |
| 25 doses | + | 50 ml |
| 50 doses | + | 100 ml |
A single dose (2 ml) of Bovilis IBR marker live mixed with Bovilis BVD is given intramuscularly.
A single dose (2 ml) of Bovilis IBR marker live mixed with Bovilis BVD is given intramuscularly.
Use sterile vaccination equipment free from disinfectants. To prevent the spread of any infective agents the intranasal equipment should be changed at each animal.
Visual appearance after reconstitution
- In Unisolve: colourless to slightly opaque solution.
- In Bovilis BVD: as specified in the product information for Bovilis BVD alone.
Overdose
At 10-fold overdose, no other effects than described under section "Adverse reactions" have been observed.
Withdrawal periods
Zero days.
Pharmacological particulars
Immunological properties
Pharmacotherapeutic group: live herpes virus vaccine
ATC-vet code: QI02AD01
To stimulate active immunity against bovine herpesvirus type 1 (BHV-1). The vaccine does not elicit antibodies to glycoprotein E of BHV-1 (marker vaccine). This enables discrimination between cattle vaccinated with this product and cattle infected with BHV-1 field virus or vaccinated with conventional non-marker BHV-1 vaccines.
Pharmaceutical particulars
Excipients
Lyophilisate:
Veggie medium, chemically defined stabiliser CD#156 (patented).
Solvent (Unisolve):
Sucrose, potassium and sodium phosphate buffers, sodium chloride, water for injections.
Major incompatibilities
Do not mix with any other veterinary medicinal product, except the diluent supplied for use with the veterinary medicinal product or with Bovilis BVD (for 6-monthly revaccination only).
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale:
Lyophilisate: 36 months.
Solvent: in glass vials: 60 months; in PET vials: 18 months.
Shelf life after reconstitution according to directions: 3 hours.
Shelf life after mixing with Bovilis BVD: 3 hours.
Special precautions for storage
Lyophilisate:
Store in a refrigerator (2 °C to 8 °C).
Do not freeze. Protect from light.
Solvent:
Store below 25°C. Do not freeze.
Vaccine after reconstitution: Store below 25 °C.
After mixing with Bovilis BVD: Store below 25 °C.
Immediate packaging
Freeze-dried vaccine:
Cardboard box with 1 or 10 vials of glass (hydrolytic type I) with rubber stopper and metal cap.
Contents per vial: 1, 2, 5, 10, 25, 50 or 100 doses.
Solvent:
Cardboard box with 1 or 10 vials of glass (hydrolytic type II) or plastic (polyethylene terephthalate) with rubber stopper and metal cap.
Contents per vial:
Glass: 2, 4, 10 or 20 ml.
Glass or PET: 50, 100 or 200 ml.
Not all pack sizes may be marketed.
Disposal
Dispose of waste material by boiling, incineration, or immersion in an appropriate disinfectant in accordance with national requirements.
Shipping charges mainland GB zone1
| Value | Weight | Delivery Charge |
| Over £49.00 | Any Weight | FREE |
| Under £49.00 | No weight limit | £4.50 |
| Under £49.00 | Under 250 grams | £3.49 |
Most orders are despatched the same day and standard delivery is 3 to 5 working days from despatch. FAST Expedited options are available at extra cost - these usually arrive in 24-48hrs from dispatch but delays are possible during busy periods.
Postcodes outside of Zone 1 (including some areas within mainland UK) may incur extra carriage charges due to surcharges imposed by the couriers. These will be calculated on the website at the checkout.
NB: Orders placed with faster delivery must be placed before 13:00 to ensure same day dispatch (excluding weekends and bank holidays). Please also check on the product page that the items ordered show 'In Stock' otherwise your order will be delayed until the stock becomes available, which in most cases will only be 24hrs.
Estimated "Usually shipped in" information is shown against most products
Overseas orders
We no longer send goods outside of the UK.
Prescription Items
Prescription items will be sent on receipt of a valid signed and dated prescription.
Pick up
We offer a pickup service for orders placed over the phone.
Please ring us on 01833 641112 for more information.
Refrigerated Items
Refrigerated items will be sent by carrier or express delivery at a cost of £7.50, with coolpacks, unless you pay for a premium for a refrigerated delivery. We will contact you prior to despatch for your instructions.
We want you to be completely satisfied with any purchase. If not any item* can be returned to us within 14 days of receipt for exchange or refund Please give us a ring for a returns number on 01833 641112 or alternatively email sales@hyperdrug.co.uk to obtain a returns number.
*Due to legal requirements medicines may not be returned except to correct an error in despatch or in response to an "official recall". If an item is believed to be faulty it should be returned for inspection and it may be necessary to forward it to the manufacturers for testing before replacements or refunds can be authorised. This does not infringe legal rights. Please contact our customer services for a "Returns Number" which must appear on the outside of the package or it will not be accepted. We advise customers to use an insured method of shipping and to retain proof of despatch. We may refuse returns on products specially obtained or manufactured to order. Items must be returned unsoiled and unused and sent adequately packed and carriage paid.
